FDA Inspection 1092608 — AmerisourceBergen Drug Corporation
The FDA completed an inspection of AmerisourceBergen Drug Corporation on May 15, 2019 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 15, 2019
- Fiscal Year
- 2019
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Kansas City, MO (United States)